Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours.
Saved in:
| Title: | Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. |
|---|---|
| Authors: | Almanza-Huante E; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Bataller A; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Urrutia S; Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Gener-Ricos G; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Briski RE; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Takahashi K; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Ravandi F; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Alvarado Y; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kadia T; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Sasaki K; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (3), pp. e25-e29. Date of Electronic Publication: 2023 Mar 23. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36951293 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Almanza-Huante+E%22">Almanza-Huante E</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Urrutia+S%22">Urrutia S</searchLink>; Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Gener-Ricos+G%22">Gener-Ricos G</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Briski+RE%22">Briski RE</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kanagal-Shamanna+R%22">Kanagal-Shamanna R</searchLink>; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Lu+KH%22">Lu KH</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Westin+SN%22">Westin SN</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Yap+TA%22">Yap TA</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Alvarado+Y%22">Alvarado Y</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kadia+T%22">Kadia T</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kantarjian+HM%22">Kantarjian HM</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2023 May; Vol. 201 (3), pp. e25-e29. <i>Date of Electronic Publication: </i>2023 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36951293 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.18766 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e25 Titles: – TitleFull: Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Almanza-Huante E – PersonEntity: Name: NameFull: Bataller A – PersonEntity: Name: NameFull: Urrutia S – PersonEntity: Name: NameFull: Gener-Ricos G – PersonEntity: Name: NameFull: Briski RE – PersonEntity: Name: NameFull: Kanagal-Shamanna R – PersonEntity: Name: NameFull: Lu KH – PersonEntity: Name: NameFull: Westin SN – PersonEntity: Name: NameFull: Yap TA – PersonEntity: Name: NameFull: Takahashi K – PersonEntity: Name: NameFull: Ravandi F – PersonEntity: Name: NameFull: Alvarado Y – PersonEntity: Name: NameFull: Kadia T – PersonEntity: Name: NameFull: Sasaki K – PersonEntity: Name: NameFull: Kantarjian HM – PersonEntity: Name: NameFull: Garcia-Manero G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2023 May Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 201 – Type: issue Value: 3 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |